NCT06687213

Brief Summary

The goal of this observational study is to learn about the long-term effects of smoking cessation on glycemic control in type 2 diabetic patients The main question it aims to answer is: Does smoking cessation lower HbA1c in type 2 diabetics on long term ? The participants will be counseled to cessate smoking and will be followed for 6 months and compared to control who will not cessate smoking .

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
178

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2024

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

November 12, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 13, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

November 13, 2024

Status Verified

October 1, 2024

Enrollment Period

1 year

First QC Date

November 12, 2024

Last Update Submit

November 12, 2024

Conditions

Smoking Cessation

Outcome Measures

Primary Outcomes (1)

  • Glycemic control after smoking cessation

    6 months

Study Arms (2)

1_Case group 2_control group

1. Case group diabetic smokers which will be counseled to cessate smoking 2. Control group diabetic smokers which will refuse to cessate smoking

Behavioral: Smoking cessation counselling group

Case control group

Case group: diabetic smokers which will cessate smoking Control group: diabetic smokers which will refuse to cessate smoking

Interventions

Smoking cessation counselling groupBEHAVIORAL

Case group will be counseled to cessate smoking and will be followed up with HbA1c

1_Case group 2_control group

Eligibility Criteria

Age35 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Community sample

You may qualify if:

  • \- Moderate Somking index Having been diagnosed with a type 2 diabetes Being ≥ 35 years old HbA1c \> 7

You may not qualify if:

  • Type 1 diabetes Drug induced Diabetes mellitus Type 2 diabetes on insulin treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assuit university

Asyut, Egypt

Location

Related Links

MeSH Terms

Conditions

Smoking Cessation

Condition Hierarchy (Ancestors)

Health BehaviorBehavior

Central Study Contacts

Alhasnaa M Rawy, Bachelor of medicine & surgery

CONTACT

+2001023801711alhsnaa.16266104@med.aun.edu.eg

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident doctor

Study Record Dates

First Submitted

November 12, 2024

First Posted

November 13, 2024

Study Start

November 1, 2024

Primary Completion

November 1, 2025

Study Completion

December 1, 2025

Last Updated

November 13, 2024

Record last verified: 2024-10

Locations

EG(1)